Research and Source Guide
Current medical guidance
- National Cancer Institute: Complementary and Alternative Medicine
- NCI: Cancer diets and supplements
- NCCIH: What people with cancer need to know
- Memorial Sloan Kettering: Hoxsey herbal therapy
- FDA: Illegally sold cancer treatments
Court opinions
- Hoxsey v. Fishbein (1949) — libel and nominal damages.
- United States v. Hoxsey Cancer Clinic (1952) — federal misbranding case and directed injunction.
Government review
- U.S. Office of Technology Assessment: Unconventional Cancer Treatments (1990)
- Archived local copy of the Hoxsey chapter
Historical artifacts
- Fitzgerald memorandum PDF — allegations and political context, not clinical proof.
- FDA warning PDF — regulatory position and public messaging.
- Harry Hoxsey's You Don't Have to Die — autobiography and advocacy source; claims require independent corroboration.
- Hoxsey: How Healing Becomes a Crime — documentary advocacy and oral history; not a clinical evaluation.
Selected ingredient research
The berberine adenoma-recurrence trial is useful for understanding a specific isolated compound and outcome. It is not evidence that the Hoxsey mixture treats colorectal cancer or any other cancer.
Checklist for evaluating a claim
- Was the diagnosis independently confirmed?
- Was the exact treatment and dose documented?
- Was there a suitable comparison group?
- Were survival, quality of life, harms, recurrence, and follow-up reported?
- Were prior or simultaneous treatments accounted for?
- Has the result been replicated by independent researchers?